Victorri-Vigneau C - Search Results

1

Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report.

Lefebvre E, Simons L, Duval M, Laforgue EJ, Victorri-Vigneau C. Lefebvre E, et al. Among authors: victorri vigneau c. J Addict Med. 2024 Sep 2. doi: 10.1097/ADM.0000000000001378. Online ahead of print. J Addict Med. 2024. PMID: 39221821

2

Multicentre study for validation of the French addictovigilance network reports assessment tool.

Victorri-Vigneau C, Hardouin JB, Rousselet M, Gerardin M, Guerlais M, Guillou M, Bronnec M, Sébille V, Jolliet P; French Addictovigilance Network. Victorri-Vigneau C, et al. Br J Clin Pharmacol. 2016 Oct;82(4):1030-9. doi: 10.1111/bcp.13044. Epub 2016 Jul 28. Br J Clin Pharmacol. 2016. PMID: 27302554 Free PMC article.

3

Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis.

Wainstein L, Victorri-Vigneau C, Sébille V, Hardouin JB, Feuillet F, Pivette J, Chaslerie A, Jolliet P. Wainstein L, et al. Int Clin Psychopharmacol. 2011 Jan;26(1):54-62. doi: 10.1097/YIC.0b013e3283400cb2. Int Clin Psychopharmacol. 2011. PMID: 20881845

4

Did the new French pay-for-performance system modify benzodiazepine prescribing practices?

Rat C, Penhouet G, Gaultier A, Chaslerie A, Pivette J, Nguyen JM, Victorri-Vigneau C. Rat C, et al. BMC Health Serv Res. 2014 Jul 11;14:301. doi: 10.1186/1472-6963-14-301. BMC Health Serv Res. 2014. PMID: 25011548 Free PMC article.

5

Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French survey.

Wainstein L, Bernier C, Gérardin M, Bouquié R, Espitia O, Mussini JM, Jolliet P, Victorri-Vigneau C. Wainstein L, et al. Br J Dermatol. 2015;172(5):1412-4. doi: 10.1111/bjd.13503. Epub 2015 Mar 9. Br J Dermatol. 2015. PMID: 25353069 No abstract available.

6

Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.

Grall-Bronnec M, Sauvaget A, Perrouin F, Leboucher J, Etcheverrigaray F, Challet-Bouju G, Gaboriau L, Derkinderen P, Jolliet P, Victorri-Vigneau C. Grall-Bronnec M, et al. J Clin Psychopharmacol. 2016 Feb;36(1):63-70. doi: 10.1097/JCP.0000000000000444. J Clin Psychopharmacol. 2016. PMID: 26658263 Free PMC article. Review.

7

Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence?

Morel A, Grall-Bronnec M, Bulteau S, Chauvin-Grelier P, Gailledrat L, Pinot ML, Jolliet P, Victorri-Vigneau C. Morel A, et al. Expert Opin Drug Saf. 2016 Oct;15(10):1313-9. doi: 10.1080/14740338.2016.1221922. Epub 2016 Aug 22. Expert Opin Drug Saf. 2016. PMID: 27501204

8

Crushed and injected buprenorphine tablets: characteristics of princeps and generic solutions.

Bouquié R, Wainstein L, Pilet P, Mussini JM, Deslandes G, Clouet J, Dailly E, Jolliet P, Victorri-Vigneau C. Bouquié R, et al. PLoS One. 2014 Dec 4;9(12):e113991. doi: 10.1371/journal.pone.0113991. eCollection 2014. PLoS One. 2014. PMID: 25474108 Free PMC article.

9

Dependence on prescription benzodiazepines and Z-drugs among young to middle-aged patients in France.

Guerlais M, Grall-Bronnec M, Feuillet F, Gérardin M, Jolliet P, Victorri-Vigneau C. Guerlais M, et al. Subst Use Misuse. 2015 Feb;50(3):320-7. doi: 10.3109/10826084.2014.980952. Epub 2014 Dec 4. Subst Use Misuse. 2015. PMID: 25474727

10

Anxiety, phobia and nadolol abuse: a case report.

Victorri-Vigneau C, Bronnec M, Prétagut S, Jolliet P. Victorri-Vigneau C, et al. Pharmacopsychiatry. 2008 Jul;41(4):165-6. doi: 10.1055/s-2008-1076725. Pharmacopsychiatry. 2008. PMID: 18651350 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters